Pharmaceutical Glass Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Description
Pharmaceutical Glass Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global pharmaceutical glass packaging market size reached US$ 8.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.1% during 2023-2028.
Glass is widely utilized as a packaging material for various pharmaceutical products. Some commonly used pharmaceutical glass packaging solutions include ultra-resistant borosilicate glass, surface treated soda-lime glass, regular soda-lime glass, and general-purpose soda-lime glass. It restricts atmospheric gases, such as carbon dioxide and oxygen, from entering the primary container, thus eliminating the risk of contamination of the medicines. It also helps extend the shelf life of pharmaceutical products and prevents the escape of volatile ingredients, thereby increasing drug stability. Moreover, colored glass, such as amber and red-colored glass, can protect the contents from ultraviolet (UV) rays and specific wavelengths. In recent years, pharmaceutical glass packaging has rapidly gained traction due to its excellent strength, durability, transparency, recyclability, and chemical resistance.
Pharmaceutical Glass Packaging Market Trends:
Pharmaceutical glass packaging protects the contents against physical damage, prevents biological contamination, and reduces the drug’s susceptibility to degradation, such as hydrolysis and oxidation. As a result, the expanding pharmaceutical industry represents the primary factor driving the market growth. Additionally, the growing need to extend the shelf life of medicinal products and the rising consumption of generic drugs and injectables are augmenting the product demand. Besides this, the widespread prevalence of chronic diseases like diabetes, increasing healthcare awareness among the masses, and elevating income levels are catalyzing the market growth. Furthermore, governments of various countries are taking several favorable initiatives to encourage the usage of recycled glass to reduce the carbon footprint and ensure a safer and greener environment. Along with this, the launch of thin and lightweight glass bottles by leading manufacturers to minimize the overall consumption of energy and raw materials is propelling the market growth. Other factors, including the emerging applications of glass bottles, improving healthcare infrastructure, rising environmental concerns, ongoing research and development (R&D) activities, and technological advancements, are also providing a positive thrust to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical glass packaging market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, drug type and application.
Breakup by Product:
Bottles
Vials
Ampoules
Cartridges and Syringes
Others
Breakup by Drug Type:
Generic
Branded
Biologic
Breakup by Application:
Oral
Injectable
Nasal
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ardagh Group S.A, Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Gerresheimer AG, Nipro Corporation, Piramal Enterprises Ltd., Schott AG, SGD Pharma, Shandong Pharmaceutical Glass Co. Ltd., Sisecam (Türkiye Is Bankasi A.S.), Stölzle-Oberglas GmBH and West Pharmaceutical Services Inc.
Key Questions Answered in This Report:
How has the global pharmaceutical glass packaging market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global pharmaceutical glass packaging market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global pharmaceutical glass packaging market and who are the key players?
What is the degree of competition in the industry?
The global pharmaceutical glass packaging market size reached US$ 8.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.1% during 2023-2028.
Glass is widely utilized as a packaging material for various pharmaceutical products. Some commonly used pharmaceutical glass packaging solutions include ultra-resistant borosilicate glass, surface treated soda-lime glass, regular soda-lime glass, and general-purpose soda-lime glass. It restricts atmospheric gases, such as carbon dioxide and oxygen, from entering the primary container, thus eliminating the risk of contamination of the medicines. It also helps extend the shelf life of pharmaceutical products and prevents the escape of volatile ingredients, thereby increasing drug stability. Moreover, colored glass, such as amber and red-colored glass, can protect the contents from ultraviolet (UV) rays and specific wavelengths. In recent years, pharmaceutical glass packaging has rapidly gained traction due to its excellent strength, durability, transparency, recyclability, and chemical resistance.
Pharmaceutical Glass Packaging Market Trends:
Pharmaceutical glass packaging protects the contents against physical damage, prevents biological contamination, and reduces the drug’s susceptibility to degradation, such as hydrolysis and oxidation. As a result, the expanding pharmaceutical industry represents the primary factor driving the market growth. Additionally, the growing need to extend the shelf life of medicinal products and the rising consumption of generic drugs and injectables are augmenting the product demand. Besides this, the widespread prevalence of chronic diseases like diabetes, increasing healthcare awareness among the masses, and elevating income levels are catalyzing the market growth. Furthermore, governments of various countries are taking several favorable initiatives to encourage the usage of recycled glass to reduce the carbon footprint and ensure a safer and greener environment. Along with this, the launch of thin and lightweight glass bottles by leading manufacturers to minimize the overall consumption of energy and raw materials is propelling the market growth. Other factors, including the emerging applications of glass bottles, improving healthcare infrastructure, rising environmental concerns, ongoing research and development (R&D) activities, and technological advancements, are also providing a positive thrust to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical glass packaging market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, drug type and application.
Breakup by Product:
Bottles
Vials
Ampoules
Cartridges and Syringes
Others
Breakup by Drug Type:
Generic
Branded
Biologic
Breakup by Application:
Oral
Injectable
Nasal
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ardagh Group S.A, Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Gerresheimer AG, Nipro Corporation, Piramal Enterprises Ltd., Schott AG, SGD Pharma, Shandong Pharmaceutical Glass Co. Ltd., Sisecam (Türkiye Is Bankasi A.S.), Stölzle-Oberglas GmBH and West Pharmaceutical Services Inc.
Key Questions Answered in This Report:
How has the global pharmaceutical glass packaging market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global pharmaceutical glass packaging market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global pharmaceutical glass packaging market and who are the key players?
What is the degree of competition in the industry?
Table of Contents
143 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Pharmaceutical Glass Packaging Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Product
- 6.1 Bottles
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Vials
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Ampoules
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Cartridges and Syringes
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 7 Market Breakup by Drug Type
- 7.1 Generic
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Branded
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Biologic
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 8 Market Breakup by Application
- 8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Injectable
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Nasal
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
- 10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
- 11 Value Chain Analysis
- 12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
- 13 Price Analysis
- 14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Ardagh Group S.A
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Beatson Clark
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Bormioli Pharma S.p.A.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Corning Incorporated
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Gerresheimer AG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Nipro Corporation
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Piramal Enterprises Ltd.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.8 Schott AG
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 SWOT Analysis
- 14.3.9 SGD Pharma
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Shandong Pharmaceutical Glass Co. Ltd.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.11 Sisecam (Türkiye Is Bankasi A.S.)
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.12 Stölzle-Oberglas GmBH
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.13 West Pharmaceutical Services Inc.
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
